SERALUTINIB
UNII 3P63ZTE3OY

Substance Identification & Data

This profile provides standardized clinical and technical data for Seralutinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3P63ZTE3OY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1619931-27-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3P63ZTE3OY

CAS Registry Number

1619931-27-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SERALUTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C27H27N5O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JHJNPOSPVGRIAN-SFHVURJKSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C175203

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

91663352

Unique identification number in the NCBI database of chemical substances.

INN ID

11243

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-05

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(cc(cn1)C)C(=O)Nc2cc(ccc2)[C@H](C)Nc3cncc(n3)-c4cc(c(cc4)OC)OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Seralutinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.